Breaking the deadlock over an Australian trial of injectable opioid maintenance

Wayne D Hall, Jo Kimber and Richard P Mattick
Med J Aust 2002; 176 (2): . || doi: 10.5694/j.1326-5377.2002.tb04289.x
Published online: 21 January 2002

Injectable heroin maintenance has been advocated as a form of treatment for opioid dependence that would attract, and retain in treatment, addicts who have either not sought treatment or who have failed at other forms of treatment, including methadone maintenance. Advocates of heroin maintenance argue that it would increase the proportion of addicts in treatment and reduce heroin use, drug-related crime, and deaths due to overdose.1

  • 1 Office of Public Policy and Ethics, Institute for Molecular Bioscience, St Lucia, QLD.
  • 2 National Drug and Alcohol Research Centre, University of New South Wales.



The authors would like to thank Professor George Bigelow, Professor Jerry Jaffe, and Dr Deborah Zador for their comments on an earlier draft of this article.

Competing interests:

None declared.

  • 1. Bammer G, Douglas RM. The ACT heroin trial proposal: an overview. Med J Aust 1996; 164: 690-692. <eMJA full text>
  • 2. Wodak A. Prescribing heroin: nothing to fear but fear itself? Med J Aust 1998; 168: 590-591. <eMJA full text>
  • 3. National Crime Authority. Organised crime in Australia. NCA Commentary 2001. Canberra: National Crime Authority, 2001.
  • 4. Jaffe J. Injectable opiate maintenance in the United Kingdom: a view from the United States. Addiction 2001; 96: 557-560.
  • 5. Bigelow GE, Becker AB, Vernotica E, Liebson IA. Comparison of heroin and hydromorphone in opiate users [abstract]. Drug Alcohol Depend 2001; 63 (Suppl 1): S14-S15.
  • 6. Meatherall R. Confirmation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in urine. J Anal Toxicol 1999; 23: 177-186.
  • 7. Hall W. Assessing the population-level impact of the Swiss model of heroin prescribing. Sydney: National Drug and Alcohol Research Centre, 1999. (Technical Report No. 76.)
  • 8. Rehm J, Geshwend P, Steffen T, et al. Feasibility, safety and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001; 358: 1417-1420.
  • 9. Perneger TV, Gina F, Del Rio M, Min A. Randomised trial of heroin maintenance program for addicts who fail in conventional drug treatment. BMJ 1998; 317: 13-18.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.